NON-HODGKIN'S LYMPHOMA
Clinical trials for NON-HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lymphoma: first human trial of ABBV 291 launches
Disease control Recruiting nowThis early-stage study tests an experimental drug called ABBV 291 in adults with Non-Hodgkin's lymphoma that has returned or stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 165 partici…
Matched conditions: NON-HODGKIN'S LYMPHOMA
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 09:10 UTC
-
New 'Four-in-One' antibody takes on tough lymphoma
Disease control Recruiting nowThis study tests a new drug called GNC-035 for people with non-Hodgkin lymphoma that has come back or stopped responding to treatment. The drug is a special antibody designed to attack cancer cells from multiple angles. The trial has two parts: first, finding the safest dose, and…
Matched conditions: NON-HODGKIN'S LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
Can we stop infections in blood cancer patients? major trial launches
Prevention Recruiting nowThis study compares two common treatments—immunoglobulin and antibiotics—to see which is better at preventing serious infections in people with blood cancers like myeloma, lymphoma, or leukemia. About 900 adults will take part. The goal is to find the safest and most effective wa…
Matched conditions: NON-HODGKIN'S LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Monash University • Aim: Prevention
Last updated May 14, 2026 12:05 UTC
-
Could your Family's lymphoma be written in your genes?
Knowledge-focused Recruiting nowThis study aims to understand why some families have more than one person with lymphoma or related blood cancers. Researchers will collect tumor samples and genetic information from 1,500 participants to look for inherited gene changes that raise cancer risk. No treatment is give…
Matched conditions: NON-HODGKIN'S LYMPHOMA
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 08:34 UTC
-
New study aims to predict outcomes for rare skin lymphoma patients
Knowledge-focused Recruiting nowThis study is collecting standardized medical data from 2,000 people with advanced mycosis fungoides or Sézary syndrome, rare types of skin lymphoma. The goal is to create a new prognostic index that helps doctors identify which patients are at higher or lower risk, so they can t…
Matched conditions: NON-HODGKIN'S LYMPHOMA
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC